1. Modern IV Iron Formulations & Pharmacokinetics
Intravenous iron is indicated for iron-deficiency anemia refractory to or intolerant of oral therapy, chronic kidney disease, inflammatory bowel disease, and severe surgical blood loss. Modern preparations consist of an iron oxyhydroxide polynuclear core encased in an engineered carbohydrate shell that stabilizes elemental iron and regulates its release to transferrin.
| IV Iron Formulation | Maximal Single Dose | Infusion Duration | Test Dose Required? | Hypersensitivity Profile |
|---|---|---|---|---|
| Ferric Carboxymaltose (Injectafer®) | 750 mg – 1,000 mg | 15 minutes | No | <0.1% (High risk of transient hypophosphatemia) |
| Iron Sucrose (Venofer®) | 200 mg – 300 mg | 15 – 30 minutes | No | ~0.002% (Extremely low immunogenicity) |
| Ferric Derisomaltose (Monoferric®) | 1,000 mg | 20 – 30 minutes | No | <0.05% |
| Ferumoxytol (Feraheme®) | 510 mg | 15 minutes | No | ~0.02% (Interferes with MRI for 3 months) |
| Low Molecular Weight Iron Dextran (INFeD®) | 1,000 mg (Total Dose) | 4 – 6 hours | Yes (25 mg test dose x 1h) | ~0.6% (Dextran-mediated antibody risk) |
2. Differentiating Fishbane Reactions from True Anaphylaxis
The most common clinical pitfall in parenteral iron administration is mistaking a benign Fishbane Reaction for life-threatening anaphylaxis:
- Fishbane Reaction (Labile Iron Complement Activation): Presents with acute self-limiting facial flushing, chest tightness, backache, arthralgia, or headache without hypotension, stridor, wheezing, or angioedema. It occurs in up to 1% of patients due to transient nanoparticle clearance saturation. Management: Temporarily pause infusion for 15 minutes. In >90% of cases, symptoms resolve completely without medical therapy. The infusion can then be safely resumed at a 50% slower rate. Over-treating Fishbane reactions with epinephrine, diphenhydramine, and pressors causes iatrogenic harm.
- True IgE-Mediated Anaphylaxis: Presents with acute systemic hypotension (systolic BP drop > 30 mmHg), laryngeal stridor, severe bronchospasm, diffuse urticaria, and angioedema. Management: Immediately terminate infusion, administer Epinephrine 0.3 mg IM in the anterolateral thigh, deliver 100% oxygen, and initiate rapid crystalloid fluid resuscitation.
3. Adverse Reaction Severity Grading & Patient Symptoms
Infusion teams must systematically grade adverse events across three distinct severity tiers:
| Severity Grade | Observable Patient Signs & Symptoms | Immediate Bedside Nursing Action |
|---|---|---|
| Mild Reaction | Mild headache, nausea, localized flushing, dysgeusia (metallic taste), mild dizziness | Slow infusion rate by 50%; provide reassurance; monitor vitals every 10 min |
| Moderate Reaction | Flank pain, marked back tightness, tachycardia, mild hypotension without shock | Pause infusion for 15 min; reassess vitals; resume at 50% if symptoms abate |
| Severe / Anaphylaxis | Stridor, acute wheezing, cardiovascular collapse, profound hypotension, angioedema | Terminate infusion; administer Epinephrine 0.3 mg IM; call Code Blue STAT |